The efficacy of high-dose tofacitinib combined with methotrexate in the treatment of refractory rheumatoid arthritis and its influence on serum anti-CCP and Th17 cytokines in patients
The Journal of Practical Medicine
2026 Vol.42 (9): 1592-1599
[Abstract]
(144)
[PDF 541 KB]
(41)
